GE Healthcare to distribute ART's eXplore Optix outside North America
15 April 2007
Montreal, Canada. ART Advanced Research Technologies Inc.
(TSX: ARA), a Canadian optical molecular imaging supplier, has signed an
agreement with GE Healthcare, regarding the worldwide distribution of its
eXplore Optix preclinical optical molecular imaging system.
Under the new agreement, ART is retaining the exclusivity to distribute
directly in North America, while GE Healthcare will have exclusivity in the
rest of the world, with a strong focus in Asia and Europe.
This will allow ART to capitalize on its market positioning in North
America to develop direct sales channels, in particular with large
pharmaceutical companies. ART will work closely with GE to take over the
responsibility to support the current installed base in North America. This
transition is expected to have a minimal impact on existing and prospective
"ART has been working closely with GE Healthcare over the last
few months to review eXplore Optix's market positioning as well as its sales
and marketing strategy. Going forward, I believe this arrangement will offer
the right conditions for a more effective commercialization of the eXplore
Optix product", said Sebastien Gignac, ART's President and CEO.